Travere Therapeutics (TVTX) Q1 2023 Earnings

4MayConfirmed
Aug 22
Oct 22
Q4 2022
Q1 2023
-1.17
-1.03
-0.9
-0.76

Details

Expected EPS
-1.17
Actual EPS
-0.82
Surprise EPS
0.35
Surprise Percent
+29.91%

Description

Travere Therapeutics (TVTX) has reported earnings of -0.82 per share for Q1 2023.

0 Comments

Share your thoughts